Amicus Therapeutics (AM6.F) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.15
-0.12
-0.09
-0.05

Details

Expected EPS
-0.05970518960000001
Actual EPS
-0.148352
Surprise EPS
-0.09
Surprise Percent
+148.47%

Description

Amicus Therapeutics (AM6.F) has reported earnings of -0.148352 per share for Q2 2024.

0 Comments

Share your thoughts